3985 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Completed Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
Condition: HIV Infections
Intervention: Drug: Tenofovir gel
22 Completed Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children
Condition: HIV Infection
Interventions: Drug: ABC Twice Daily;   Drug: ABC Once Daily;   Drug: 3TC Once Daily;   Drug: 3TC Twice Daily
23 Completed A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men
Condition: HIV Infections
Intervention: Behavioral: Behavioral intervention to reduce sexual risk among African-American men who have sex with men
24 Completed A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Cycloserine;   Drug: Ethionamide;   Drug: Capreomycin sulfate;   Drug: Aminosalicylic acid;   Drug: Streptomycin sulfate;   Drug: Ethambutol hydrochloride;   Drug: Amikacin sulfate;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Pyridoxine hydrochloride;   Drug: Levofloxacin;   Drug: Rifampin;   Drug: Clofazimine
25 Completed Healthy Teen Girls: HIV Risk Reduction
Condition: HIV-infection/Aids
Intervention: Behavioral: Cognitive-behavioral HIV/STD risk reduction
26 Recruiting Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients
Condition: Hiv Infection
Intervention: Biological: blood sampling,
27 Completed DDI Study of Etravirine and GSK1265744
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1265744
28 Completed A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine/Zidovudine;   Biological: Hepatitis A Vaccine (Inactivated);   Drug: Interleukin-12;   Drug: Nevirapine;   Drug: Stavudine;   Drug: Sargramostim
29 Completed Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe
Conditions: Circumcision Adult;   HIV CDC Category B2;   HIV Infections
Intervention: Device: PrePex™ device
30 Completed A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
Conditions: Cytomegalovirus Infections;   HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine;   Drug: Ganciclovir
31 Recruiting Cryotherapy vs. LEEP to Treat CIN2/3 Among HIV-positive Women
Condition: Cervical Intraepithelial Neoplasia
Interventions: Procedure: Loop Electrosurgical Excision Procedure (LEEP);   Procedure: Cryotherapy
32 Completed A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Early versus intermediate versus late initiation of ART
33 Completed Connect to Protect Partnerships for Youth Prevention Interventions: Phase II
Condition: HIV Infection
Intervention:
34 Completed Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
Condition: HIV Infection
Intervention:
35 Active, not recruiting Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Conditions: HIV;   HIV Infections
Intervention: Drug: E/C/F/TAF
36 Completed A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Intervention: Drug: Doxorubicin hydrochloride
37 Completed A Study of CI-1012 in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: CI-1012
38 Completed The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: indinavir/ritonavir
39 Active, not recruiting Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC rAd5 vaccine (rAd5 gag-pol/env A/B/C);   Biological: rAd5 env A;   Biological: rAd5 env B;   Biological: rAd5 env C;   Biological: rAd5 gag-pol;   Biological: Placebo Vaccine
40 Unknown  SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Conditions: HIV Infections;   Lipodystrophy
Interventions: Drug: atazanavir (Reyataz);   Drug: ritonavir (Norvir)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years